prof. MUDr. Jiří Mayer, CSc.

2024

• Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study

  POTT Christiane JURINOVIC Vindi TROTMAN Judith KEHDEN Britta UNTERHALT Michael HEROLD Michael RICHARD van der Jagt JANSSENS Ann KNEBA Michael MAYER Jiří YOUNG Moya SCHMIDT Christian KNAPP Andrea NIELSEN Tina BROWN Helen SPIELEWOY Nathalie HARBRON Chris BOTTOS Alessia MUNDT Kirsten MARCUS Robert HIDDEMANN Wolfgang HOSTER Eva

  Peer-reviewed scientific article

  Journal of clinical oncology, year: 2024, volume: 42, edition: 5, DOI

• MOLECULAR MECHANISM OF NON-GENETIC ADAPTATION TO BTK INHIBITOR THERAPY IN CLL

  ONDRIŠOVÁ Laura ŠEDA Václav HLAVÁČ Kryštof HOFERKOVÁ Eva PAVELKOVÁ Petra KOŠŤÁLOVÁ Lenka FILIP Daniel FARIA ZENI Pedro PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka SIMKOVIC M. VRBACKÝ F. LYSÁK Daniel DAVIDS MS. MARTIN-SUBERO JI. BROWN JR. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

  Conference abstract

  Year: 2024, type: Conference abstract

• Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes

  PERUSINI Maria Agustina ŽÁČKOVÁ Daniela KIM TaeHyung PAGNANO Katia B B PAVLOVSKY Carolina JEŽÍŠKOVÁ Ivana KVETKOVÁ Anežka JURČEK Tomáš KIM Jaeyoon John YOO Young Seok YI Seongyoon LEE Hyewon KIM Kyoung Ha CHANG Myunghee JOSE-MARIO Capo-Chichi MEDEIROS Jessie ARRUDA Andrea MINDEN Mark D ZHANG Zhaolei ABELSON Sagi MAYER Jiří KIM Dennis Dong Hwan

  Peer-reviewed scientific article

  Blood advances, year: 2024, volume: 8, edition: 10, DOI

• Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors

  JANOVSKÁ Pavlína RADASZKIEWICZ Tomasz Witold PROCHAZKOVA P PRIŠTICOVÁ Ingrid PLEŠINGEROVÁ Hana ČULEN Martin ŠMÍDA Michal BUŠA Daniel LADUNGOVÁ Adriana MAIER Lukáš HAVEL Štěpán MAYER Jiří SCHEER A PARUCH Kamil BRYJA Vítězslav

  Conference abstract

  Year: 2024, type: Conference abstract, DOI

• Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

  GEISSLER Klaus KORISTEK Zdenek BERNAL del Castillo Teresa NOVAK Jan RODRIGUEZ-MACIAS Gabriela METZELDER Stephan K ILLES Arpad MAYER Jiří ARNAN Montserrat KEATING Mary-Margaret KRAUTER Juergen LUNGHI Monia FRACCHIOLLA Nicola Stefano PLATZBECKER Uwe SANTINI Valeria SANO Yuri OGANESIAN Aram KEER Harold LUEBBERT Michael

  Peer-reviewed scientific article

  British journal of haematology, year: 2024, volume: 205, edition: 5, DOI

• Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial

  TROTMAN Judith ZINZANI Pier Luigi SONG Yuqin DELARUE Richard KIM Pil IVANOVA Elena KORDE Rasika MAYER Jiří DE OLIVEIRA Ana C ASSOULINE Sarit E FLOWERS Christopher R BARNES Gisoo

  Peer-reviewed scientific article

  Current medical research and opinion, year: 2024, volume: 40, edition: 11, DOI

• PILOTNÍ STUDIE SLEDOVÁNÍ ZMĚN SLOŽENÍ STŘEVNÍHO MIKROBIOMU U PACIENTŮ S HEMATOLOGICKOU MALIGNITOU POMOCÍ NANOPÓROVÉHO SEKVENOVÁNÍ

  BEZDÍČEK Matěj NYKRÝNOVÁ Markéta KABUT Tomáš WEINBERGEROVÁ Barbora REINEROVÁ Zuzana MAYER Jiří LENGEROVÁ Martina

  Conference abstract

  Year: 2024, type: Conference abstract

• Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment

  BROWN Jennifer R EICHHORST Barbara HILLMEN Peter JURCZAK Wojciech KAZMIERCZAK Maciej LAMANNA Nicole O'BRIEN Susan M TAM Constantine S QIU Lugui ZHOU Keshu SIMKOVIC Martin MAYER Jiří GILLESPIE-TWARDY Amanda FERRAJOLI Alessandra GANLY Peter S WEINKOVE Robert GROSICKI Sebastian MITAL Andrzej ROBAK Tadeusz OSTERBORG Anders YIMER Habte A SALMI Tommi WANG Megan-Der-Yu FU Lina LI Jessica WU Kenneth COHEN Aileen SHADMAN Mazyar

  Article in Periodical (without peer review)

  Year: 2024, type: Article in Periodical (without peer review), DOI

• POROVNÁNÍ ÚČINNOSTI A BEZPEČNOSTI LÉČBY IMATINIBEM NEBO NILOTINIBEM V PRVNÍ LINII U PACIENTŮ S CHRONICKOU MYELOIDNÍ LEUKEMIÍ – ANALÝZA DAT Z REGISTRU INFINITY

  BĚLOHLÁVKOVÁ Petra ŽÁČKOVÁ Daniela KLAMOVÁ H FABER Edgar KARAS M. STEJSKAL L. CMUNT E. ČERNÁ O. MACHOVÁ POLÁKOVÁ Kateřina JEŽÍŠKOVÁ Ivana VOGLOVÁ J. ŽÁK P. JURKOVÁ T CHRÁPAVÁ M MAYER Jiří

  Conference abstract

  Year: 2024, type: Conference abstract

• Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study

  LUCINI Chantal OBROVA Klara KRICKL Isabella NOGUEIRA Filomena KOCMANOVA Iva HERNDLHOFER Susanne GLEIXNER Karoline V SPERR Wolfgang R FRANK Tijana ANDRADE Nuno PETERS Christina ENGSTLER Gernot DWORZAK Michael ATTARBASCHI Andishe VAN GROTEL Martine VAN DEN HEUVEL-EIBRINK Marry M MOISEEV Ivan S ROGACHEVA Yuliya ZUBAROVSKAYA Ludmilla ZUBAROVSKAYA Natalia PICHLER Herbert LAWITSCHKA Anita KOLLER Elisabeth KEIL Felix MAYER Jiří WEINBERGEROVÁ Barbora VALENT Peter LION Thomas

  Peer-reviewed scientific article

  JOURNAL OF HEMATOLOGY & ONCOLOGY, year: 2024, volume: 17, edition: 1, DOI